AJR Women's Imaging Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korogi, Y.
Right arrow Articles by Uji, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korogi, Y.
Right arrow Articles by Uji, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 165, 1269-1272, Copyright © 1995 by American Roentgen Ray Society


ARTICLES

Superselective intraarterial infusion of cisplatin for squamous cell carcinoma of the mouth: preliminary clinical experience

Y Korogi, T Hirai, R Nishimura, S Hamatake, Y Sakamoto, R Murakami, Y Baba, A Arakawa, M Takahashi and Y Uji
Department of Radiology, Kumamoto University School of Medicine, Japan.

OBJECTIVE. The purpose of this study was to assess the initial clinical response to superselective intraarterial infusion of cisplatin for treating stage III and stage IV squamous cell carcinoma of the mouth. SUBJECTS AND METHODS. Thirteen patients received intraarterial cisplatin therapy. The tumors were located in the tongue (n = 7), gingiva (n = 3), buccal mucosa (n = 1), hard palate (n = 1), and floor of the mouth (n = 1). A coaxial technique was used to place microcatheters in the lingual, facial, inferior alveolar, buccinator, and distal internal maxillary arteries, depending on tumor location. The feeding vessels were identified by staining the tumor with infusion of indigocarmine dye in the selected vessel. Relatively low-dose cisplatin (30-40 mg/m2) was injected at the rate of 50 mg/hr. Two or three injections were performed, with a 1-week interval between injections. After chemotherapy, eight patients underwent surgery, four had radiation therapy, and one had both. RESULTS. Thirty-four intraarterial infusions were done successfully without any complications. Arterial infusion of indigocarmine dye was useful for exact identification of feeding vessels, especially when the tumor was extensive, at the margin of the arterial supply, or near the midline. The overall response rate was 92% (complete response [tumor completely resolved], 38%; partial response [tumor reduction > or = 50%], 54%). Ten of 13 patients had no recurrence from 4 to 19 months (mean, 10 months) after treatment. Two patients died of metastatic diseases 6 months after surgery or radiation therapy. One patient had local recurrence 8 months after surgery and postoperative irradiation. No systemic toxicity such as renal failure, liver dysfunction, or bone marrow suppression was observed. Mild and transient local toxicity such as edema or mucositis of the infused area was relatively common. Trigeminal neuralgialike symptoms and reduced mouth opening occurred in two cases and one case, respectively, probably due to direct toxicity to the peripheral trigeminal nerve and masticatory muscles, respectively. CONCLUSION. Superselective intraarterial infusion of low- dose cisplatin is feasible and safe and may have important applications in treating advanced carcinoma of the mouth.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
S. Kakeda, Y. Korogi, Y. Miyaguni, J. Moriya, N. Ohnari, N. Oda, K. Nishino, and W. Miyamoto
A Cone-Beam Volume CT Using a 3D Angiography System with a Flat Panel Detector of Direct Conversion Type: Usefulness for Superselective Intra-arterial Chemotherapy for Head and Neck Tumors
AJNR Am. J. Neuroradiol., October 1, 2007; 28(9): 1783 - 1788.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
B. Damascelli, G. L. Patelli, R. Lanocita, G. D. Tolla, L. F. Frigerio, A. Marchiano, F. Garbagnati, C. Spreafico, V. Ticha, C. R. Gladin, et al.
A Novel Intraarterial Chemotherapy Using Paclitaxel in Albumin Nanoparticles to Treat Advanced Squamous Cell Carcinoma of the Tongue: Preliminary Findings
Am. J. Roentgenol., July 1, 2003; 181(1): 253 - 260.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
K.-i. Satoh, N. Sakamoto, Y. Shinohe, M. Satoh, and S. Joh
Indigo Carmine-Induced Bradycardia in a Patient During General Anesthesia
Anesth. Analg., January 1, 2001; 92(1): 276 - 277.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
T. Nakasato, K. Katoh, M. Sone, S. Ehara, Y. Tamakawa, H. Hoshi, and S. Sekiyama
Superselective Continuous Arterial Infusion Chemotherapy through the Superficial Temporal Artery for Oral Cavity Tumors
AJNR Am. J. Neuroradiol., November 1, 2000; 21(10): 1917 - 1922.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
K. Kishi, M. Matsunaka, M. Sato, T. Sonomura, M. Sakurane, and K. Uede
T1 and T2 Lip Cancer: A Superselective Method of Facial Arterial Infusion Therapy-Preliminary Experience
Radiology, October 1, 1999; 213(1): 173 - 179.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Roentgen Ray Society.